Vigilant Capital Management, LLC Merck & Co., Inc. Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 6,719 shares of MRK stock, worth $575,146. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,719

Previous 6,719 -0.0%

Holding current value

$575,146

Previous $715,000 8.39%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$102.94 - $114.86 $72,058 - $80,402	-700 Reduced 9.44%	6,719 $715,000
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $122,853 - $157,514	1,405 Added 23.36%	7,419 $823,000
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $10,481 - $11,775	-124 Reduced 2.02%	6,014 $518,000
Q2 2022 Jul 06, 2022	BUY	$83.49 - $94.64 $11,688 - $13,249	140 Added 2.33%	6,138 $560,000
Q1 2022 Apr 07, 2022	SELL	$73.51 - $82.4 $154,371 - $173,040	-2,100 Reduced 25.93%	5,998 $492,000
Q4 2021 Jan 06, 2022	BUY	$72.28 - $90.54 $102,276 - $128,114	1,415 Added 21.17%	8,098 $621,000
Q3 2021 Oct 08, 2021	BUY	$71.68 - $78.83 $24,657 - $27,117	344 Added 5.43%	6,683 $502,000
Q2 2021 Jul 09, 2021	BUY	$70.31 - $77.77 $128,034 - $141,619	1,821 Added 40.31%	6,339 $493,000
Q1 2021 Apr 16, 2021	SELL	$68.86 - $81.11 $77,467 - $91,248	-1,125 Reduced 19.94%	4,518 $348,000
Q4 2020 Jan 14, 2021	BUY	$71.77 - $79.65 $11,411 - $12,664	159 Added 2.9%	5,643 $462,000
Q3 2020 Oct 15, 2020	BUY	$73.18 - $82.95 $24,588 - $27,871	336 Added 6.53%	5,484 $455,000
Q2 2020 Jul 10, 2020	SELL	$70.42 - $80.13 $62,814 - $71,475	-892 Reduced 14.77%	5,148 $398,000
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $82,368 - $114,165	-1,300 Reduced 17.71%	6,040 $465,000
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $23,506 - $26,524	-303 Reduced 3.96%	7,340 $668,000
Q3 2019 Oct 16, 2019	BUY	$76.08 - $82.93 $111,228 - $121,243	1,462 Added 23.65%	7,643 $643,000
Q2 2019 Jul 18, 2019	SELL	$69.84 - $81.59 $9,288 - $10,851	-133 Reduced 2.11%	6,181 $518,000
Q1 2019 Apr 09, 2019	SELL	$69.58 - $79.36 $1.19 Million - $1.36 Million	-17,118 Reduced 73.05%	6,314 $525,000
Q4 2018 Jan 15, 2019	BUY	$65.24 - $75.71 $14,287 - $16,580	219 Added 0.94%	23,432 $1.79 Million
Q3 2018 Oct 11, 2018	BUY	$57.69 - $67.84 $955,346 - $1.12 Million	16,560 Added 248.91%	23,213 $1.65 Million
Q2 2018 Jul 11, 2018	SELL	$50.83 - $59.72 $2,541 - $2,986	-50 Reduced 0.75%	6,653 $404,000
Q1 2018 Apr 04, 2018	BUY	$50.96 - $59.23 $50,501 - $58,696	991 Added 17.35%	6,703 $365,000
Q4 2017 Jan 31, 2018	BUY	$51.62 - $61.64 $209,886 - $250,628	4,066 Added 247.02%	5,712 $321,000
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $96,570 - $103,911	1,646	1,646 $105,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $217B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Merck & Co., Inc. Transaction History